Posted by Max Byerly on Jun 15th, 2011
Affymetrix, Inc. (AFFX) has been resumed with new coverage from the research analysts at Wedbush. Wedbush begins coverage resumption of Affymetrix with a new price target set at $7 dollars, and rates performance of AFFX as ‘neutral,’...
More of this article »